Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year AstraZeneca PLC grew net income 129.12% from 1.23bn to 2.83bn despite declining revenues.
Gross margin82.17%
Net profit margin9.03%
Operating margin14.96%
Return on assets3.63%
Return on equity13.96%
Return on investment4.98%
More ▼

Cash flow in USDView more

In 2015, AstraZeneca PLC did not generate a significant amount of cash. However, the company earned 3.32bn from its operations for a Cash Flow Margin of 13.45%. In addition the company generated 878.00m cash from financing while 4.24bn was spent on investing.
Cash flow per share2.88
Price/Cash flow per share16.78
Book value per share8.78
Tangible book value per share-18.01
More ▼

Balance sheet in USDView more

AstraZeneca PLC has a Debt to Total Capital ratio of 53.32%, a higher figure than the previous year's 45.42%.
Current ratio0.9292
Quick ratio0.7602
Total debt/total equity1.30
Total debt/total capital0.5332
More ▼

Growth rates in USD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 128.94%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)0.09%
Div growth rate (5 year)1.89%
Payout ratio (TTM)108.15%
EPS growth(5 years)-16.70
EPS (TTM) vs
TTM 1 year ago
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.